UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lack of growth inhibitory synergism with combined MAPK/PI3K inhibition in preclinical models of pancreatic cancer

Annals of oncology, 2017-11, Vol.28 (11), p.2896-2898

2017

Volltextzugriff (PDF)

The biphasic role of SEMA3A in PDAC progression

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2021-07, Vol.21, p.S15-S15

2021

Volltextzugriff (PDF)

A clinical–biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status

Annals of oncology, 2013-03, Vol.24 (3), p.693-701

2013

Volltextzugriff (PDF)

Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2022-11, Vol.22, p.e69-e69

2022

Volltextzugriff (PDF)

Unrevealing the role of lymph node metastases in PDAC progression

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2021-07, Vol.21, p.S3-S3

2021

Volltextzugriff (PDF)

Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries

Annals of oncology, 2012-01, Vol.23 (1), p.127-134

2012

Volltextzugriff (PDF)

A lysosomal lipid switch sensitizes to nutrient deprivation and mTOR targeting in pancreatic cancer

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2022-11, Vol.22, p.e76-e77

2022

Volltextzugriff (PDF)

Modelling evolution of PDAC towards aggressive phenotypes using the organoid culture system

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2021-07, Vol.21, p.S43-S43

2021

Volltextzugriff (PDF)

Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models

Annals of oncology, 2018-10, Vol.29, p.viii665-viii665

2018

Volltextzugriff (PDF)

Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers

Annals of oncology, 2019-07, Vol.30, p.iv50-iv50

2019

Volltextzugriff (PDF)

Map kinase activity drives a subtype specific subset of CAFS in PDAC

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2021-07, Vol.21, p.S2-S2

2021

Volltextzugriff (PDF)

Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations

Annals of oncology, 2018-10, Vol.29, p.viii511-viii512

2018

Volltextzugriff (PDF)

Results of an integrated multi-platforms analysis in squamous cell lung carcinoma (SqCLC) revealed PI3K/RICTOR-mTORC2 axis as a potential prognostic biomarker and druggable target

Annals of oncology, 2017-10, Vol.28, p.vi57-vi57

2017

Volltextzugriff (PDF)

Profiling mTOR pathway in neuroendocrine tumors

Targeted oncology, 2012-09, Vol.7 (3), p.183-188

2012

Volltextzugriff (PDF)

194 Pancreatic ductal organoids as a new platform for drug discovery

European journal of cancer (1990), 2014-11, Vol.50, p.63-63

2014

Volltextzugriff (PDF)

Update on the Molecular Pathogenesis of Pancreatic Tumors Other than Common Ductal Adenocarcinoma

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2009-01, Vol.9 (1-2), p.25-33

2009

Volltextzugriff (PDF)

Combinatorial Effect of Magnetic Field and Radiotherapy in Pancreatic Ductal Adenocarcinoma Organoids

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e248-e248

2021

Volltextzugriff (PDF)

30P Assessing the potential role of RICTOR expression as predictive factor of response to PI3K/mTOR pathway inhibitors in preclinical models of squamous cell lung cancer

Annals of oncology, 2020-03, Vol.31, p.S10

2020

Volltextzugriff (PDF)

In vivo suppression of Bcl‐XL expression facilitates chemotherapy‐induced leukaemia cell death in a SCID/NOD‐Hu model

British journal of haematology, 2001-03, Vol.112 (3), p.706-713

2001

Volltextzugriff (PDF)

236P A novel microfluidic platform for understanding the role of PDAC stroma in immune response

Immuno-oncology technology, 2022-12, Vol.16, p.100347, Article 100347

2022

Volltextzugriff (PDF)

1879PPotential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

P-186Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers

Annals of oncology, 2019-07, Vol.30 (Supplement_4)

2019

Volltextzugriff (PDF)

P2.04-51 A 6-Gene Immune Genomic Signature (IGS) Predicts Resistance to Nivolumab [NIV] in Advanced Pretreated NSCLC: Results of PRINCiPe Trial

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S728-S728

2019

Volltextzugriff (PDF)

1584PExploring resistance to nivolumab [NIV] applying an Immune Genomic Signature (IGS) in advanced pretreated NSCLC [PRINCiPe study]

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1584P - Exploring resistance to nivolumab [NIV] applying an Immune Genomic Signature (IGS) in advanced pretreated NSCLC [PRINCiPe study]

Annals of oncology, 2019-10, Vol.30, p.v653-v653

2019

Volltextzugriff (PDF)

1 – 25 von 319

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(261)
Mit Volltextzugriff
(280)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lack of growth inhibitory synergism with combined MAPK/PI3K inhibition in preclinical models of pancreatic cancer

The biphasic role of SEMA3A in PDAC progression

A clinical–biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status

Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma

Unrevealing the role of lymph node metastases in PDAC progression

Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries

A lysosomal lipid switch sensitizes to nutrient deprivation and mTOR targeting in pancreatic cancer

Modelling evolution of PDAC towards aggressive phenotypes using the organoid culture system

Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models

Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers

Map kinase activity drives a subtype specific subset of CAFS in PDAC

Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations

Results of an integrated multi-platforms analysis in squamous cell lung carcinoma (SqCLC) revealed PI3K/RICTOR-mTORC2 axis as a potential prognostic biomarker and druggable target

Profiling mTOR pathway in neuroendocrine tumors

194 Pancreatic ductal organoids as a new platform for drug discovery

Update on the Molecular Pathogenesis of Pancreatic Tumors Other than Common Ductal Adenocarcinoma

Combinatorial Effect of Magnetic Field and Radiotherapy in Pancreatic Ductal Adenocarcinoma Organoids

30P Assessing the potential role of RICTOR expression as predictive factor of response to PI3K/mTOR pathway inhibitors in preclinical models of squamous cell lung cancer

In vivo suppression of Bcl‐XL expression facilitates chemotherapy‐induced leukaemia cell death in a SCID/NOD‐Hu model

236P A novel microfluidic platform for understanding the role of PDAC stroma in immune response

1879PPotential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models

P-186Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers

P2.04-51 A 6-Gene Immune Genomic Signature (IGS) Predicts Resistance to Nivolumab [NIV] in Advanced Pretreated NSCLC: Results of PRINCiPe Trial

1584PExploring resistance to nivolumab [NIV] applying an Immune Genomic Signature (IGS) in advanced pretreated NSCLC [PRINCiPe study]

1584P - Exploring resistance to nivolumab [NIV] applying an Immune Genomic Signature (IGS) in advanced pretreated NSCLC [PRINCiPe study]

Suchergebnisse filtern